Avoro Capital Advisors LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2019$48,520,000
-2.9%
1,000,000
+5.3%
2.02%
+17.2%
Q2 2019$49,970,000
-0.6%
950,0000.0%1.73%
-20.6%
Q1 2019$50,284,000
+250.0%
950,000
+171.4%
2.17%
+153.1%
Q4 2018$14,368,000
+31.5%
350,000
+21.7%
0.86%
+71.1%
Q3 2018$10,925,000
-65.5%
287,500
-59.0%
0.50%
-58.8%
Q2 2018$31,665,000
-63.5%
700,548
-63.5%
1.22%
-70.6%
Q1 2018$86,720,000
+19.6%
1,917,548
+4.1%
4.14%
-11.9%
Q4 2017$72,479,000
+107.6%
1,841,896
+63.8%
4.70%
+73.5%
Q3 2017$34,910,000
+48.4%
1,124,300
+30.7%
2.71%
-8.8%
Q2 2017$23,521,000
-21.7%
860,000
+5.5%
2.97%
-22.6%
Q1 2017$30,033,000
+108.7%
815,000
-18.2%
3.84%
+32.0%
Q4 2016$14,390,000
-28.2%
995,838
+14.6%
2.91%
-17.3%
Q3 2016$20,037,000
+25.3%
869,263
-9.8%
3.52%
-1.0%
Q2 2016$15,987,000
+384.5%
963,646
+363.1%
3.55%
+208.7%
Q1 2016$3,300,000208,0861.15%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders